Gastrointestinal and metabolic problems associated with immunosuppression with either CyA or FK 506 in liver transplantation.
Van Thiel
D H
DH
Department of Surgery, University of Pittsburgh, PA.
Iqbal
M
M
Jain
A
A
Fung
J
J
Todo
S
S
Starzl
T E
TE
D000681:Amylases / Q000097:blood; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D001786:Blood Glucose / Q000378:metabolism; D002784:Cholesterol / Q000097:blood; D003524:Cyclosporins / Q000009:adverse effects*; D004064:Digestive System / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016031:Liver Transplantation; D016559:Tacrolimus; D014527:Uric Acid / Q000097:blood
D000900:Anti-Bacterial Agents; D001786:Blood Glucose; D003524:Cyclosporins; D007166:Immunosuppressive Agents; D014527:Uric Acid; D002784:Cholesterol; D000681:Amylases; D016559:Tacrolimus